Cargando…

Recent Advances in Oligonucleotide Therapeutics in Oncology

Cancer is one of the leading causes of death worldwide. Conventional therapies, including surgery, radiation, and chemotherapy have achieved increased survival rates for many types of cancer over the past decades. However, cancer recurrence and/or metastasis to distant organs remain major challenges...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Haoyu, Veedu, Rakesh N., Diermeier, Sarah D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036554/ https://www.ncbi.nlm.nih.gov/pubmed/33804856 http://dx.doi.org/10.3390/ijms22073295

Ejemplares similares

Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation
por: Raguraman, Prithi, et al.
Publicado: (2021)

Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics
por: Le, Bao T., et al.
Publicado: (2018)

BACE1 Inhibition Using 2’-OMePS Steric Blocking Antisense Oligonucleotides
por: Chakravarthy, Madhuri, et al.
Publicado: (2019)

Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures
por: Rahimizadeh, Kamal, et al.
Publicado: (2017)

Development of a Novel DNA Oligonucleotide Targeting Low-Density Lipoprotein Receptor
por: Wang, Tao, et al.
Publicado: (2019)

Evaluation of DNA segments in 2′-modified RNA sequences in designing efficient splice switching antisense oligonucleotides
por: Le, Bao T., et al.
Publicado: (2021)

Novel Disulfide-Bridged Bioresponsive Antisense Oligonucleotide Induces Efficient Splice Modulation in Muscle Myotubes in Vitro
por: Le, Bao T., et al.
Publicado: (2020)

Efficient Epidermal Growth Factor Receptor Targeting Oligonucleotide as a Potential Molecule for Targeted Cancer Therapy
por: Wang, Tao, et al.
Publicado: (2019)

Recent Advancements in Development and Therapeutic Applications of Genome-Targeting Triplex-Forming Oligonucleotides and Peptide Nucleic Acids
por: Mikame, Yu, et al.
Publicado: (2023)

Systematic Screening of Commonly Used Commercial Transfection Reagents towards Efficient Transfection of Single-Stranded Oligonucleotides
por: Wang, Tao, et al.
Publicado: (2018)

Recent advances in radiation oncology
por: Garibaldi, Cristina, et al.
Publicado: (2017)

Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
por: Chen, Suxiang, et al.
Publicado: (2019)

Recent Advances in Antisense Oligonucleotide Therapy in Genetic Neuromuscular Diseases
por: Verma, Ashok
Publicado: (2018)

Consequences of Making the Inactive Active Through Changes in Antisense Oligonucleotide Chemistries
por: Zaw, Khine, et al.
Publicado: (2019)

Therapeutic Advances in Oncology
por: Liu, Jinsha, et al.
Publicado: (2021)

Author Correction: Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
por: Chen, Suxiang, et al.
Publicado: (2020)

Thiomorpholino oligonucleotides as a robust class of next generation platforms for alternate mRNA splicing
por: Le, Bao T., et al.
Publicado: (2022)

Rational Design of Short Locked Nucleic Acid-Modified 2′-O-Methyl Antisense Oligonucleotides for Efficient Exon-Skipping In Vitro
por: Le, Bao T., et al.
Publicado: (2017)

Systematic Combination of Oligonucleotides and Synthetic Polymers for Advanced Therapeutic Applications
por: Han, Moohyun, et al.
Publicado: (2021)

Alpha-l-Locked Nucleic Acid-Modified Antisense Oligonucleotides Induce Efficient Splice Modulation In Vitro
por: Raguraman, Prithi, et al.
Publicado: (2020)

Circular RNAs: Potential Applications as Therapeutic Targets and Biomarkers in Breast Cancer
por: Sarkar, Debina, et al.
Publicado: (2021)

Nonviral delivery systems for antisense oligonucleotide therapeutics
por: Huang, Si, et al.
Publicado: (2022)

Therapeutically Significant MicroRNAs in Primary and Metastatic Brain Malignancies
por: Balachandran, Akilandeswari A., et al.
Publicado: (2020)

Recent advances of PET imaging in clinical radiation oncology
por: Unterrainer, M., et al.
Publicado: (2020)

Advances in Antisense Oligonucleotide Development for Target Identification, Validation, and as Novel Therapeutics
por: Mansoor, Moizza, et al.
Publicado: (2008)

Recent Advances of Magnetic Nanomaterials in the Field of Oncology
por: Li, Tianyang, et al.
Publicado: (2020)

Synthesis of a Morpholino Nucleic Acid (MNA)-Uridine Phosphoramidite, and Exon Skipping Using MNA/2′-O-Methyl Mixmer Antisense Oligonucleotide
por: Chen, Suxiang, et al.
Publicado: (2016)

Recent Methods for Purification and Structure Determination of Oligonucleotides
por: Zhang, Qiulong, et al.
Publicado: (2016)

Antisense Oligonucleotide Therapeutics for Cystic Fibrosis: Recent Developments and Perspectives
por: Kim, Young Jin, et al.
Publicado: (2023)

DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics
por: Larcher, Leon M., et al.
Publicado: (2023)

Recent Advances in Nucleic Acid Targeting Probes and Supramolecular Constructs Based on Pyrene-Modified Oligonucleotides
por: Krasheninina, Olga A., et al.
Publicado: (2017)

Imaging in oncology: Recent advances
por: Arya, Supreeta
Publicado: (2015)

Recent advances in oncological endourology
por: Chiu, Allen W.
Publicado: (2016)

Advances in oligonucleotide drug delivery
por: Roberts, Thomas C., et al.
Publicado: (2020)

Oligonucleotide Therapeutics
por: Stein, Cy A., et al.
Publicado: (2010)

RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
por: Bajan, Sarah, et al.
Publicado: (2020)

Advances in Oligonucleotide Aptamers for NSCLC Targeting
por: Rotoli, Deborah, et al.
Publicado: (2020)

Recent advances in liver transplantation for cancer: The future of transplant oncology
por: Abreu, Phillipe, et al.
Publicado: (2019)

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
por: Hammond, Suzan M, et al.
Publicado: (2021)

Emerging Oligonucleotide Therapeutics for Rare Neuromuscular Diseases
por: Aoki, Yoshitsugu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_64g6rd511ljovak67ubp8tl1i6